Charlotte's Web Holdings, Inc. · TSX:CWEB

Charlotte's Web — Investor Presentation (May 2023)

25 slides from Charlotte's Web's investor presentation, May 2023

  1. Slide 1: May 2023 Investor Presentation

    May 2023 TSX: CWEB | OTCQX: CWBHF Charlotte’s Web, Inc. 1

  2. Slide 2: Disclaimers

    DISCLAIMERS Forward-Looking Information Certain statements contained in this presentation constitute forward-looking statements and forward-looking information (collectively, “forward-looking statements”). Such forward-looking statements relate to possible events, conditions or financial performance

  3. Slide 3: Charlotte's Web was started as a mission

    C H A R LOT T E ’ S W E B WA S N OT S TA R T E D A S A C O M PA N Y, I T WA S S TA R T E D A S A M I S S I O N , A N D L AU N C H E D T H E C B D C AT EG O RY. What began as her story, became the shared story of thousands, and the inspiration of millions in the journey of betterment. Charlotte remai

  4. Slide 4: Full & Broad Spectrum Hemp Extract Products

    Full & Broad Spectrum Hemp Extract Products Nature in a bottle: plant intelligence for today and tomorrow’s wellness consumer Coming Soon! Comin g Soon! Charlotte’s Web, Inc. 4

  5. Slide 5: Competitive Differentiation

    Competitive Differentiation 10 Years in the Making, Prepared for the Future • • 1. Vertical • Integration • • • 2. Science & • 4 1 Safety • • • 3 2 3. Production • Capacity • • 4. #1 Products & • Market Share • • Charlotte’s Web, Inc. 5

  6. Slide 6: Substantial Market Upside: #1 in a Fragmented Market

    Charlotte’s Web #1 in SUBSTANTIAL a Fragmented Market MARKET UPSIDE CW holds 6% of share in segments it participates in; 3% of total market $3bn market share available Enormous room for market share gains through its products capitalization, regulation and competitor reduction $4.4B Aggregate US CBD

  7. Slide 7: Charlotte's Web is #1 in Purchase Consideration

    Purchase Consideration Charlotte's Web is #1 in purchase consideration 7

  8. Slide 8: CW has #1 share in ecommerce channel

    CW has #1 share -4%- in ecommerce channel Charlotte’s Web, Inc. 8

  9. Slide 9: 2022: Addressed Liquidity

    Quarterly Revenue 2022: addressed liquidity & Operating Expenses • 21.4* 20.4 19.4 18.9 18.9 17.5** 17.317.0 17.0. • 15.1 • • • Q1 Q2 Q3 Q4 Q1 '23 Charlotte’s Web, Inc. 9

  10. Slide 10: 3-Pillar Strategy

    3-Pillar STRATEGY Our mission is “to unlock the healing power of botanicals with compassion and science benefiting the planet and all who live upon it” 1 2 3 Charlotte’s Web, Inc. 10

  11. Slide 11: Accessing scale and new retail verticals

    Accessing scale and new retail verticals.... • • • • • Charlotte’s Web, Inc. 11

  12. Slide 12: ECommerce: Targeting New Customers

    ECommerce: Targeting New Customers 1 2 3 4 5 6 Charlotte’s Web, Inc. 12

  13. Slide 13: Charlotte's Web, Inc.

    THE.GAME Is PLAYED IN MY MIND. MY MENTAL AND PHYSICAL HEALTH ARE ONE IN THE SAME. =e ReCreate ©

  14. Slide 14: ReCreate Phase One: Sport & Fitness

    Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com. ©/™ 2022 MLB RECREATE™ PHASE ONE: SPORT & FITNESS HUGE POTENTIAL UPSIDE AMONG YOUNGER CBD CONSUMERS WITH RECREATE™ REACT REFUEL RESET GET IN THE GAME STAY IN THE GAME CHANGE THE GAME Cha

  15. Slide 15: Charlotte’s Web, Inc.

    Charlotte’s Web, Inc. 15

  16. Slide 16: Regulatory Progress Toward NDI

    Regulatory Progress Toward NDI New Dietary Ingredient (Dietary Supplement Category) Charlotte’s Web, Inc. 16

  17. Slide 17: Botanical Drug Pathway Toward IND

    Botanical Drug Pathway Toward IND Pharmaceutical Investigative New Drug (IND) through FDA • • • • • • • • Charlotte’s Web, Inc. 17

  18. Slide 18: Joint Venture with BAT and AJNA BioSciences

    | Charlotte's Web forms Joint Venture with BAT and AJNA BioSciences to Seek FDA-Approval for Proprietary Full Spectrum Hemp Extract Botanical Drug CHARLOTTE’S WEB BAT acquires 20% stake for US$10 million, with Charlotte's Web and AJNA each owning 40% Renowned neurologist Dr. Orrin Devinsky, Chief Me

  19. Slide 19: Formation of Defloria LLC

    FORMATION OF “DEFLORIA llc” PARTNERING TO PURSUE BOTANICAL DRUG THROUGH FDA BAT 20% CW 40% AJNA 40% 4 Charlotte’s Web, Inc. 19

  20. Slide 20: Leadership team to execute

    Leadership team to execute Jacques Tortoroli Jared Stanley COO Jessica Saxton CEO CFO Former President of Bacardi Co-founder of Charlotte’s Web. Former General Motors and International. Joined Charlotte’s Has led plant sciences, breeding, Anheuser-Bush InBev executive with Web Board of Directors Nov

  21. Slide 21: Positioned to deliver long term shareholder value

    • POSITIONED • To deliver long term • shareholder value • • • Low valuation relative to long-term potential • Charlotte’s Web, Inc. 21 * MLB 6.1M shares (4%) shareholder, BAT proforma 19.9% shareholder post conversion @C$2.00 Nov 2029

  22. Slide 22: Charlotte's Web, Inc. - Information

    Charlotte’s Charlotte’sWeb, Web,Inc. Inc. - Confidential Information 22

  23. Slide 23: Charlotte's Web, Inc.

    CHARLOTTE’S WEB’ STANLEY BROTHERS TSX:CWEB | OTCQX:CWBHF Charlotte’s Web Holdings, Inc. 700 Tech Court Louisville, Colorado USA www.charlottesweb.com Cory Pala Director of Investor Relations (720) 484-8930 IR@CharlottesWeb.com 23

  24. Slide 24: Capitalization

    CAPITALIZATION CAPITALIZATION March 31, 2023 Basic Common Shares Outstanding Restricted Share Units Options Fully Diluted Shares 162.7 Outstanding 24 Charlotte’s Web, Inc. 24

  25. Slide 25: Recapitalized: $56.8M Strategic Investment from BAT

    RECAPITALIZED $56.8M Strategic Investment from BAT Investment Highlights Capitalization + Ownership November 2022 Net Cash Position $67.0M ✓ ✓ Dec 31, 2022 5.0% - 1.5% ✓ Annualized Cost 2 stepping down upon federal legalization 2 1 ✓ ~19.9% 3 BAT Ownership upon conversion 1. Interest to be settled i

Charlotte's Web Holdings — Investor Presentation (May 2023) on 6ix